TTD | Drug: D0V2NQ

Drug General Information
Drug ID	D0V2NQ
Former ID	DNC009564
Drug Name	N-(3-Phenyl)propyl-2,2-diphenylacetamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529563]
Structure		Download 2D MOL 3D MOL
Formula	C23H23NO
Canonical SMILES	C1=CC=C(C=C1)CCCNC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3
InChI	1S/C23H23NO/c25-23(24-18-10-13-19-11-4-1-5-12-19)22(20-14-6-2-7-15-20)21-16-8-3-9-17-21/h1-9,11-12,14-17,22H,10,13,18H2,(H,24,25)
InChIKey	GGASESVHBWYDKY-UHFFFAOYSA-N
PubChem Compound ID	2385541
Target and Pathway
Target(s)	Cannabinoid receptor 1	Target Info	Inhibitor	[529563]
KEGG Pathway	Rap1 signaling pathway
	Neuroactive ligand-receptor interaction
	Retrograde endocannabinoid signaling
PANTHER Pathway	Endogenous cannabinoid signaling
Pathway Interaction Database	N-cadherin signaling events
Reactome	Class A/1 (Rhodopsin-like receptors)
Reactome	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Small Ligand GPCRs
	BDNF signaling pathway
	GPCR ligand binding
	GPCR downstream signaling
	GPCRs, Other
References
Ref 529563	Bioorg Med Chem. 2008 Aug 1;16(15):7510-5. Epub 2008 Jun 7.Novel sterically hindered cannabinoid CB1 receptor ligands.
Ref 529563	Bioorg Med Chem. 2008 Aug 1;16(15):7510-5. Epub 2008 Jun 7.Novel sterically hindered cannabinoid CB1 receptor ligands.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information